Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF - PubMed (original) (raw)
Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF
J A Hamilton et al. Arterioscler Thromb Vasc Biol. 1999 Jan.
Abstract
Modification of low density lipoprotein (LDL), eg, by oxidation, has been proposed as being important for the formation of foam cells and therefore for the development of atherosclerotic plaques. There are a number of reports showing that macrophage-derived foam cells can proliferate in both human and animal lesions, particularly in the early phase of the disease and possibly involving macrophage-colony stimulating factor (M-CSF, or CSF-1). We studied the in vitro effects of oxidized LDL (ox-LDL) on murine bone marrow-derived macrophages (BMMs), a cell population with a high proliferative capacity in vitro in response to CSF-1 and a dependence for survival on the presence of this growth factor. We report here that treatment of BMMs with low doses of ox-LDL, but not with native LDL, led to cell survival, DNA synthesis, and an enhanced response to the proliferative actions of CSF-1 and granulocyte macrophage-CSF (GM-CSF); the effects were dependent on the degree of LDL oxidation. For CSF-1, a synergistic effect was noticeable at suboptimal doses. The effect of ox-LDL occurred even in the absence of endogenous CSF-1 or GM-CSF. Our findings suggest that ox-LDL, and possibly other modified forms of LDL, could maintain macrophage (and foam cell) survival and therefore lengthen their tenure in a plaque; the modified LDL could also cause local macrophage proliferation or "prime" them so that they could proliferate better in response to CSF-1 (and GM-CSF) concentrations that may be present in the atheroma.
Similar articles
- Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1).
Hamilton JA, Byrne R, Jessup W, Kanagasundaram V, Whitty G. Hamilton JA, et al. Biochem J. 2001 Feb 15;354(Pt 1):179-87. doi: 10.1042/0264-6021:3540179. Biochem J. 2001. PMID: 11171093 Free PMC article. - Granulocyte/macrophage colony-stimulating factor plays an essential role in oxidized low density lipoprotein-induced macrophage proliferation.
Biwa T, Sakai M, Shichiri M, Horiuchi S. Biwa T, et al. J Atheroscler Thromb. 2000;7(1):14-20. doi: 10.5551/jat1994.7.14. J Atheroscler Thromb. 2000. PMID: 11425039 Review. - Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor.
Biwa T, Hakamata H, Sakai M, Miyazaki A, Suzuki H, Kodama T, Shichiri M, Horiuchi S. Biwa T, et al. J Biol Chem. 1998 Oct 23;273(43):28305-13. doi: 10.1074/jbc.273.43.28305. J Biol Chem. 1998. PMID: 9774454 - Macrophage proliferation in atherosclerosis.
Sakai M, Kobori S, Miyazaki A, Horiuchi S. Sakai M, et al. Curr Opin Lipidol. 2000 Oct;11(5):503-9. doi: 10.1097/00041433-200010000-00008. Curr Opin Lipidol. 2000. PMID: 11048893 Review.
Cited by
- Neutrophil-to-lymphocyte ratio is associated with stroke progression and functional outcome in patients with ischemic stroke.
Xu C, Cai L, Yi T, Yi X, Hu Y. Xu C, et al. Brain Behav. 2023 Nov;13(11):e3261. doi: 10.1002/brb3.3261. Epub 2023 Sep 24. Brain Behav. 2023. PMID: 37743586 Free PMC article. - MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.
Yu M, Zhou H, Zhao J, Xiao N, Roychowdhury S, Schmitt D, Hu B, Ransohoff RM, Harding CV, Hise AG, Hazen SL, DeFranco AL, Fox PL, Morton RE, Dicorleto PE, Febbraio M, Nagy LE, Smith JD, Wang JA, Li X. Yu M, et al. J Exp Med. 2014 May 5;211(5):887-907. doi: 10.1084/jem.20131314. Epub 2014 Apr 21. J Exp Med. 2014. PMID: 24752299 Free PMC article. - Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis.
Pulanco MC, Cosman J, Ho MM, Huynh J, Fing K, Turcu J, Fraser DA. Pulanco MC, et al. J Immunol. 2017 Jan 1;198(1):472-480. doi: 10.4049/jimmunol.1601445. Epub 2016 Nov 28. J Immunol. 2017. PMID: 27895181 Free PMC article. - Antiinflammatory and immunomodulatory properties of statins.
Shovman O, Levy Y, Gilburd B, Shoenfeld Y. Shovman O, et al. Immunol Res. 2002;25(3):271-85. doi: 10.1385/IR:25:3:271. Immunol Res. 2002. PMID: 12018465 Review. - Ox-LDL modifies the behaviour of bone marrow stem cells and impairs their endothelial differentiation via inhibition of Akt phosphorylation.
Chu L, Hao H, Luo M, Huang Y, Chen Z, Lu T, Zhao X, Verfaillie CM, Zweier JL, Liu Z. Chu L, et al. J Cell Mol Med. 2011 Feb;15(2):423-32. doi: 10.1111/j.1582-4934.2009.00948.x. J Cell Mol Med. 2011. PMID: 19863696 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous